PSA tests lead to overdiagnosis3rd August 2006
Further evidence has shown widespread screening for prostate cancer would result in massive overdiagnosis and treatment.
Researchers from Cambridge University and the Wolfson Institute of Preventive Medicine, report in the British Journal of Cancer, that more than half of cases who underwent the prediagnosis prostate specific antigen (PSA) test are likely to have been overdiagnosed. This means the cancer would not have been detected clinically in their lifetime without the PSA testing.
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: PSA tests lead to overdiagnosis
Author: Chris May
Article Id: 594
Date Added: 3rd Aug 2006